''Intra-luminal interleukin (IL)-27 is a potential future therapeutic for inflammatory bowel disease'

In this section
''Intra-luminal interleukin (IL)-27 is a potential future therapeutic for inflammatory bowel disease'
-

This is a past event

Dr Mairi McLean, 3Is Programme, Institute of Medical Sciences, University of Aberdeen

Immunity, Infection and Inflammation Seminar Programme